Overview
US rodent birth control maker's Q1 revenue grew 2%, driven by direct-to-consumer sales
Gross margin reached a record 68.6% as direct channel economics improved
Net loss widened due to severance and legal costs related to strategic transition
Outlook
Company expects e-commerce website redesign to launch in Q3 2026 to support subscription growth
SenesTech sees strong momentum in direct-to-consumer and subscription business following Amazon transition
Company continues to pursue B2B vertical expansion and international opportunities for growth
Result Drivers
DIRECT-TO-CONSUMER GROWTH - Revenue growth was driven by a 42% increase in direct-to-consumer sales, attributed to strong Amazon execution and subscription growth
SUBSCRIPTION REVENUE - Subscription revenue rose 44%, reinforcing the recurring nature of the company's direct-to-consumer business model
B2B CHANNELS - B2B revenue increased 57% due to continued traction across distributor, municipal, and professional channels
Company press release: ID:nPn31mcvCa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$493,000
$632,000 (1 Analyst)
Q1 Net Income
Miss
-$2.06 mln
-$1.74 mln (1 Analyst)
Q1 Income From Operations
Miss
-$2.12 mln
-$1.73 mln (1 Analyst)
Q1 Basic EPS
-$0.39
Q1 Gross Profit
$338,000
Q1 Operating Expenses
$2.46 mln
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the agricultural chemicals peer group is "buy"
Wall Street's median 12-month price target for Senestech Inc is $10.00, about 478% above its May 11 closing price of $1.73
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)